Myriad Genetics (MYGN) Announces Proposed $100M Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Myriad Genetics Announces Proposed Offering of $100 Million of Shares of Common Stock
November 8, 2023 4:10 PM ESTSALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN) (the Company or Myriad Genetics), a leader in genetic testing and precision medicine, today announced that it plans to make a public offering of $100.0 million of shares of its common stock, par value $0.01 per share (common stock), in an underwritten registered public offering. The Company also expects to grant the underwriters a 30-day option to purchase up to $15.0 million of additional shares of its common stock. The offering is subject to market and other conditions, and there can be no... More
